Approximately 40% of the world's population is at risk for Plasmodium vivax malaria. 1 Resistance to chloroquine and other antimalarials is more likely for Plasmodium falciparum than other Plasmodium species, and species identification is important to select appropriate treatment.
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The gold standard for diagnosing malaria is microscopic examination of thick and thin blood films. However, timely, high-quality microscopy may be unavailable in resource-poor settings. Immunochromatographic rapid diagnostic tests (RDTs) are alternatives to microscopic diagnosis. Pan-specific RDTs distinguish P falciparum (or mixed) infections from infections with only nonfalciparum species; differentiation between nonfalciparum species (P vivax from Plasmodium ovale and Plasmodium malariae) is not possible. More recently developed, vivax-specific RDTs can detect P vivax monoinfection or co-infection. This JAMA Clinical Evidence Synopsis summarizes a Cochrane review 2 assessing the accuracy of RDTs for detecting P vivax and nonfalciparum malaria in endemic countries.
Summary of Findings
In 8 studies of vivax-specific RDTs, involving 3682 participants of whom 531 had vivax malaria, sensitivities ranged from 66% to 100% and specificities ranged from 98% to 100%. In pooled analyses, compared with microscopy, vivax-specific RDTs had a sensitivity of 95% (95% CI, 86%-99%) and specificity of 99% (95% CI, 99%-100%) (Table) . For pan-specific RDTs, the sensitivities from individual studies varied from 25% to 100% and had wide 95% CIs. Specificities varied between 89% and 100% and had narrow CIs. Where there were sufficient data, we compared the accuracy of commercial brands within each type of panspecific RDT, and there was no association of commercial brand with superior sensitivity or specificity. The variability and uncertainty in sensitivity estimates are probably due to the small number of malaria cases in some studies. The mean specificity of each of the 3 types of pan-specific RDTs was high (Table) , with approximately 1% to 2% of noncases being false-positives when compared with microscopy. Conversely, mean sensitivities were low, with false-negative rates for nonfalciparum species between 11% and 22%.
Discussion
In P vivax endemic areas, vivax-specific RDTs have higher sensitivity for malaria than pan-specific RDTs. Pan-specific RDTs may be useful in areas where the majority of malaria is caused by P falciparum or mixed infection because they are sensitive for the detection of P falciparum.
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When we updated our search in December 2014, we found 4 additional studies that meet the review inclusion criteria. Three of the studies, with sample sizes of 677 participants, 4 1762 participants, 5 and 200 participants, 6 respectively, compared vivax-specific RDTs with microscopy. Their findings were consistent with those for studies included in the published review, although Vyas et al 4 found a lower specificity (90%). Inclusion of the 3 new studies in an updated meta-analysis of vivax-specific RDTs gave a mean sensitivity of 94% (95% CI, 86%-98%) and a mean specificity of 99% (95% CI, 98%-100%), similar to those of the original meta-analysis. The fourth new study by Chong et al, with a sample size of 185 participants assessed a type 3 panspecific RDT against microscopy and polymerase chain reaction for detection of nonfalciparum malaria. The study by Chong et al was consistent with the included studies for type 3 RDTs, and is unlikely to change the conclusions of the review.
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CLINICAL QUESTION How sensitive and specific are rapid diagnostic tests (RDTs) for diagnosing Plasmodium vivax and nonfalciparum malaria in endemic areas?
BOTTOM LINE Vivax-specific RDTs were highly sensitive and specific when compared with microscopy (the gold standard) for detecting P vivax malaria. RDTs that can only distinguish Plasmodium falciparum from nonfalciparum malaria were less sensitive.
Evidence Profile
No. of studies: 37 publications reporting 47 study cohorts Conducted, 1998 Conducted, -2011 published, 1999 -2013 Last search date: December 31, 2013
Study years:
No. of participants: 22 862 with symptoms suggestive of uncomplicated malaria
Men: 8304 (56%) Women: 6399 (44%); only 34 studies (14 703 participants) reported sex
